Litigation Details for FOREST LABORATORIES, LLC v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2017)
✉ Email this page to a colleague
FOREST LABORATORIES, LLC v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2017)
Docket | ⤷ Sign Up | Date Filed | 2017-10-31 |
Court | District Court, D. New Jersey | Date Terminated | 2018-02-08 |
Cause | 35:271 Patent Infringement | Assigned To | Esther Salas |
Jury Demand | None | Referred To | Michael A. Hammer |
Patents | 8,481,598; 8,865,937; RE43,879 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in FOREST LABORATORIES, LLC v. ZYDUS PHARMACEUTICALS (USA) INC.
Details for FOREST LABORATORIES, LLC v. ZYDUS PHARMACEUTICALS (USA) INC. (D.N.J. 2017)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2017-10-31 | 1 | United States Patent Nos. 8,481,598 (“the ’598 patent”), 8,865,937 (“the ’937 patent”), and RE43,879… said patents under 35 U.S.C. § 271(a); d) declare that United States Patent Nos. 8,481,598, 8,865,937… infringed United States Patent Nos. 8,481,598, 8,865,937, and RE43,879 by submitting ANDA…PageID: 15 before United States Patent Nos. 8,481,598 and RE43,879 expire, would constitute…expiration date of United States Patent Nos. 8,481,598, 8,865,937, and RE43,879, including any | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |